Abstract
Introduction
Recently, attention has been drawn to the junction between the fimbrial mucosa and the tubal serosa as well as to the junction between the fimbrial mucosa and the ovarian surface epithelium as the location of origin of some forms of epithelial ovarian cancer. [1] [2] [3] Serous tubal intraepithelial carcinoma (STIC) has been identified in the fallopian tubes of prophylactic salpingo-oophorectomies of BRCA mutation carriers with a predilection for the fimbriae in about 90% of cases. 2, 4 STIC is now considered a putative precursor lesion of most extrauterine high-grade serous carcinomas (HGSC). It is frequently reported in high-risk women and women with advancedstage serous carcinoma. 5, 6 Proceedings in Obstetrics and Gynecology, 2019;9(1): 6 
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This case study reports HGSC associated with a bilateral STIC at the fimbrial ends and infundibular regions of the fallopian tubes, and local stromal invasion in the left tube, with a primary presentation with ascites and consequent peritoneal biopsy showing peritoneal HGSC, followed by Wertheim´s operation including pelvic lymphadenectomy.
Extensively examined pelvic lymph nodes were negative for tumor, and there was no evidence of lymphatic vessel involvement. Thus, this case may provide evidence for a contiguous spread of tumor cells from a STIC by exfoliation and transcoelomic spread to the peritoneal surface.
Case Report
A 42 year old woman presented with increasing abdominal circumference lasting for five days. She complained of flank pain and hematuria. Her familial history was unremarkable. She was para 2, had a tubal ligation 15 years ago, was postmenopausal for four years and was treated for adnexitis three months prior. Serologically, inflammatory parameters were elevated. On physical examination, transvaginal ultrasound showed moderate free fluid in the abdominal cavity, but uterus and adnexa were unremarkable. The value of CA125 was elevated to 682.1 kU/L.
On computed tomography, nodular consolidations of the omentum were noted. There were no signs of bulky lymphadenopathy. Diagnostic paracentesis yielded bloody fluid. On cytological examination, three dimensional papillary clusters with significant nuclear polymorphism, hyperchromasia, and nucleoli were noted. The nuclei were placed eccentrically in the cytoplasm which showed some vacuolization. These findings were interpreted as malignant cells consistent with a papillary serous adenocarcinoma, a primary lesion of the peritoneum or the female genital tract. A subsequent core biopsy of the omental mass revealed HGSC. On immunohistochemistry, the tumor was strongly positive for WT1 and p53, consistent with a tubo-ovarian or peritoneal primary. A diagnostic laparoscopy followed by subsequent laparotomy was performed. The abdominal situs revealed a greater omentum abnormally thickened by grayish white tumor masses in diffuse and nodular configurations, consistent with an omental cake, while small stipple-like tumor deposits were seen on the bladder peritoneum. Uterus, ovaries and fallopian tubes were grossly unremarkable. A frozen section from the omental biopsy confirmed the previously diagnosed HGSC. The surgical report noted no infiltration of the omental tumor into the greater curvature of the stomach or transverse colon, and the omental cake was resected completely. There was no tumor involvement noted in the liver or spleen. The preliminary surgical diagnosis was suspicious for a primary peritoneal carcinoma. Peritoneal lavage yielded carcinoma cells. Surgical therapy included hysterectomy, bilateral salpingo-oophorectomy, and resection of the omentum majus and the peritoneal tumor deposits as well as pelvic lymphadenectomy. The latter was done for optimal staging since the site of the primary tumor was uncertain prior to surgery, and there was no evidence of suspicious lymph nodes from either surgery or imaging. No visible tumor was left at the end of the operation. The patient gave written consent to the use of her case for this study.
Figure 1.
Histologically, the omental tumor displayed a mixed architecture of solid nests, abortive tubuli, and papillary structures associated with occasional psammoma bodies ( Figure 1 ). Small tumor nests were noted in optically clear spaces, consistent with micropapillary growth patterns. Areas of hemorrhagic tumor necrosis as well as an interstitial round cell inflammatory infiltrate were seen. There was high-grade nuclear pleomorphism, with variation in size. The nuclear chromatin was coarse with patchy nuclear clearings. Large nucleoli were observed frequently. There was no evidence of mucin as demonstrated by PAS-Alcian stain. Immunohistochemically, the tumor was diffusely positive for cytokeratin 7, p53 in strong diffuse nuclear patterns, and p16.
The tumor cells were immunonegative for cytokeratin 20, calretinin, estrogen receptor, CEA, and TTF1. The rate of proliferation by Ki-67 was at 80%. Mitoses with frequently atypical configurations were a common finding, with about 40 figures in 10 high power fields (X400), as were apoptotic bodies. Small tumor deposits were noted at the uterine and fallopian tube serosa bilaterally. PAX8 immunostaining showed typical nuclear reactivity of the omental lesion as well as the STICs. Since morphology and immunoprofiles of the STICs, omental and peritoneal lesions were consistent with serous high grade neoplasia, no further immunostains were performed (e.g., SATB2 for colorectal carcinoma which is CD20 positive in the vast majority of Proceedings in Obstetrics and Gynecology, 2019;9(1):6
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The normal-appearing tubes, including the fimbriated ends, were sectioned extensively following the SEE-FIM protocol. 7 Both tubes were embedded completely; the fimbriated ends were sectioned longitudinally. Cross sections of the tubes were cut at approximately 3 mm intervals along the horizontal axis, the fimbriated ends were amputated and sectioned parallel to the long axis at 2 mm intervals. Histologically, the tubal mucosa was unremarkable in most of the slides. However, neoplastic proliferations were observed at the infundibular regions and the fimbrial ends of both tubes. These epithelia were characterized by marked nuclear atypia with hyperchromasia, irregular outlines, increased size, exhibited stratification and crowding, loss of polarity, tufting, papillary growth patterns, and high nuclear-tocytoplasmic ratios (Figures 2,3) . They appeared comparable to the above described tumor masses morphologically as well as immunohistochemically by the antibodies described above. In particular, there was diffuse and strong nuclear p53 expression and Ki67 indices were high (Figure 4 ). Occasional psammoma bodies were noted. In the infundibulum of the left tube, a small neoplastic focus of about 1mm diameter infiltrated into the tubal lamina propria. In both tubes, tumor aggregates were detached to the tubal lumens extensively (Figures 4,5) .
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Figure 5.
There was no evidence of lymphovascular invasion, as confirmed by CD31 immunostaining, consistent with L/V0 for staging purposes. CD31 is a sensitive marker for vascular and lymphatic endothelia that is used routinely in our laboratory. Another option would be the use of D2-40, a specific and sensitive marker for just lymphatic endothelia. However, this antibody was not applied in this case since there was no evidence of involvement of any endothelial lined spaces by tumor cells. In total, 27 regional lymph nodes were submitted for histology, sectioned in 2 mm intervals, investigated in serial sections including cytokeratin 7 immunohistochemistry, and all were found to be free of tumor metastases, micrometastases, or isolated tumor cells. Additionally, the ovaries were microscopically free of tumor. A final diagnosis of a bilateral STIC associated with a unilateral focus of invasive tubal HGSC and peritoneal HGSC was rendered. The author interpreted these findings as consistent with a primary lesion in the fallopian tubes, and a stage of FIGO IIIC was assigned.
The patient received six cycles of chemotherapy (Taxol/Carboplatin/Avastin) and is on maintenance Avastin. There is no sign of tumor recurrence 25 months out from surgery.
Genetic testing was not performed secondary to financial concerns.
Discussion
The origin of most non uterine HGSC in the fallopian tubes due to germline BRCA 1/2 mutations is well recognized in the recent literature. 8 Additionally, sporadic cases of non-uterine HGSC have been shown to arise in the Proceedings in Obstetrics and Gynecology, 2019;9(1):6
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fallopian tube fimbria in the majority of cases, providing further evidence for the tubal origin of these neoplasms. 8 To this end, the diagnostic potential of complete examination of the fallopian tubes to identify such STICs has been emphasized. 9 This case study does not just add another case of STIC to the literature. Rather, it attempts to consider and discuss a bilateral STIC with unilateral tube wall infiltration and associated peritoneal HGSC, without evidence of lymphovascular space involvement and regional lymph node metastases. Foci of lamina propria infiltration in STIC cases have been recognized previously. 8 Bilateral STICs are mentioned in different studies. 8, 10 However, bilaterality is observed in a minority of cases only. The question has been raised whether STIC could represent a secondary metastatic spread from nongynecologic sites. Rabban et al. reported on tumors metastasizing to the fallopian tube mucosa with a predominance of adenocarcinomas and most frequent primaries in the colon and breast, potentially resembling STIC.
11
Rare metastases originated from lymphomas, neuroendocrine carcinomas, and mesotheliomas. They pointed to a frequent expression of p53 as a potential diagnostic pitfall in such lesions. In the present case, the immunohistochemical, histochemical and morphologic profile as described above is consistent with a HGSC.
Bilateral tubal STIC with unilateral focally invasive HGSC associated with peritoneal disease also needs to be investigated for a mutual relationship. Kuhn et al. investigated TP53 mutations in STIC and concurrent pelvic HGSC. 12 Their findings support a clonal relationship of these entities, and demonstrate the utility of p53 immunostaining as a surrogate for TP53 mutation in the histological diagnosis of STIC.
They emphasized the importance of appreciation of a diffuse strong staining that correlates with a missense mutation, whereas complete absence of staining correlates with null mutations. A positive staining was recorded by =60% of reactive nuclei. Important for the study at hand is the observation that multiple STICs were generally p53 positive. 12 This case was finally interpreted as bilateral STIC with peritoneal metastatic spread. This decision was made based on previous studies. Kuhn et al. reported that the vast majority of STICs showed shortened telomeres, one of the earliest molecular changes in carcinogenesis. 13 The majority of corresponding HGSC showed longer telomeres. The authors interpreted these findings as a further support to the proposal that STICs are precursors of HGSC. Bashashati et al. found TP53 to be the only somatic mutation consistently present in all samples of the HGSC that they investigated using spatial mutational profiling. They also noted that the fallopian tube lesion was ancestral based on phylogenetic mapping. 14 Based on TP53 sequencing, Singh et al. 15 suggested that STIC can even metastasize to the contralateral adnexa without peritoneal involvement.
The spread of the tubal lesion in this case to the peritoneal surface and omentum majus needs further consideration. Tumor cell clusters of different sizes were noted in the lumina of both tubes. They appear as a result of 
Conclusion
On the basis of the criteria and studies discussed above, this author made a pragmatic decision as to the primary site, as proposed previously. 16 The site of the primary lesion was assigned as tubal rather than peritoneal in the presence of a bilateral STIC and a locally invasive carcinoma in the absence of signs of lymphatic invasion, suggesting transcoelomic dissemination of metastasizing tumor cells. To the best of the author´s knowledge, this is the first report applying an extensive protocol to all investigated lymph nodes with serial sections and cytokeratin 7 immunohistochemistry to exclude evidence of lymphatic spread.
